SCHEMBL5507684

SCHEMBL5507684

COc1ccc2ncnc(OCC3CCC(NC(=O)OCc4ccccc4)CN3C(=O)OC(C)(C)C)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
ACHE P22303 2/20 0.40
SLC2A1 P11166 1/20 0.40
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
ABCB1 P08183 1/20 0.39
PIK3CD O00329 2/20 0.38
PIK3CA P42336 2/20 0.38
PIK3CB P42338 2/20 0.38
PIK3CG P48736 2/20 0.38
EGFR P00533 2/20 0.38
ERBB2 P04626 1/20 0.38
TSHR P16473 1/20 0.38
CTSL P07711 1/20 0.37
CTSB P07858 1/20 0.37
CTSK P43235 1/20 0.37
TLR9 Q9NR96 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5511774 0.82 MTNR1B (0.47) ALDH1A1MTNR1AMTNR1BPIK3CDPIK3CA
SCHEMBL5511779 0.82 MTNR1B (0.47) ALDH1A1MTNR1AMTNR1BPIK3CDPIK3CA
SCHEMBL5511776 0.82 MTNR1B (0.47) ALDH1A1MTNR1AMTNR1BPIK3CDPIK3CA
SCHEMBL5520227 0.77 ALDH1A1 (0.45) CA1CA2ACHEALDH1A1GAA
SCHEMBL1224568 0.75 KIT (0.55) CA1CA2ACHEMTNR1BEGFR
SCHEMBL632999 0.73 PIK3CD (0.51) SLC2A1MTNR1AMTNR1BPIK3CDPIK3CA
SCHEMBL22601784 0.72 ALDH1A1 (0.55) CA1CA2ACHEALDH1A1GAA
SCHEMBL16204631 0.71 ABCB1 (0.51) CA1CA2ACHEALDH1A1GAA
SCHEMBL20480178 0.71 ABCB1 (0.50) CA1CA2ACHEALDH1A1GAA
SCHEMBL143840 0.71 ABCB1 (0.50) CA1CA2ACHEALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799676-A2 NEW BICYCLIC ANTIBIOTICS Actelion Pharmaceuticals Ltd. (CH) 2007-06-27 EP disclosed
WO-2006032466-A2 NEW BICYCLIC ANTIBIOTICS ACTELION PHARMACEUTICALS LTD (CH) 2006-03-30 WO disclosed